Arrowhead Pharmaceuticals (ARWR) vs Elanco Animal Health (ELAN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Arrowhead Pharmaceuticals (ARWR) has outperformed Elanco Animal Health (ELAN) over the past year, gaining 64.4% versus a gain of 10.8%. Over five years, ARWR leads with a -8.2% price change compared with -30.7% for ELAN. Elanco Animal Health is the larger company by market cap ($11.26 billion vs $8.56 billion), about 1.3 times the size, while Arrowhead Pharmaceuticals is growing revenue faster (+23258.2% vs +6.2%).
Arrowhead Pharmaceuticals converts more of its revenue into profit, with a net margin of -0.2% versus -4.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARWR | ELAN |
|---|---|---|
| Share price | $60.61 | $22.54 |
| Market cap | $8.56B | $11.26B |
| 1-day change | -0.21% | +0.04% |
| YTD return | -8.51% | -0.40% |
| 1-year return | +64.43% | +10.82% |
| 5-year return | -8.19% | -30.73% |
| Forward P/E | — | 17.54 |
| EPS (TTM) | $-2.28 | $-0.41 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $829.45M | $4.71B |
| Revenue growth (YoY) | +23258.15% | +6.22% |
| Net income (latest FY) | $-1.63M | $-232.00M |
| Gross margin | — | 54.99% |
| Operating margin | 11.86% | — |
| Net margin | -0.20% | -4.92% |
| 52-week high | $95.49 | $27.98 |
| 52-week low | $34.61 | $19.40 |
| Distance from 52-week high | -36.53% | -19.44% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +76.92% | +37.53% |
| Average volume | 1.91M | 6.19M |
| Shares outstanding | 141.25M | 499.45M |
| Employees | 711 | 9,400 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ARWR has outperformed ELAN by 53.6 percentage points over the past year.
- Arrowhead Pharmaceuticals grew revenue faster in its latest fiscal year (+23258.15% vs +6.22%).
About Arrowhead Pharmaceuticals
ARWR stock →Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 711 employees
About Elanco Animal Health
ELAN stock →Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark.
Health Care · Biotechnology: Pharmaceutical Preparations · 9,400 employees
ARWR vs ELAN FAQ
Which is bigger, Arrowhead Pharmaceuticals or Elanco Animal Health?
Elanco Animal Health (ELAN) is larger, with a market capitalization of $11.26B compared with $8.56B for Arrowhead Pharmaceuticals (ARWR).
Which stock has performed better over the past year, ARWR or ELAN?
ARWR returned +64.43% over the past 12 months, compared with +10.82% for ELAN (price return, excluding dividends). Past performance does not predict future results.
Are Arrowhead Pharmaceuticals and Elanco Animal Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.